Skip to content
Conference Open access

Phytocompounds of Cajanus Cajan as Potential Anti-Breast Cancer Agents: an Analysis Through Network Pharmacology and Molecular Docking

Oct 2026 · Book of Abstracts of the 10th DeKUT International Conference on Science, Technology, Innovation and Entrepreneurship (STI&E 2026) · 0 citations

Abstract

Breast cancer is a leading cause of death among women. Cajanus cajan has been shown to have anticancer activity on breast cancer cells. This study explored the anti-breast cancer potential of Cajanus cajan through network pharmacology and molecular docking techniques. Phytocompounds of Cajanus cajan were retrieved from literature and the IMPPAT 2.0 database. The compounds were filtered through Lipinski's rule and ADMET properties, and their target genes were predicted using Swiss Target Prediction and the similarity ensemble approach (SEA). Differentially expressed genes in breast cancer were retrieved from the Gene Expression Omnibus, GeneCards, and OMIM databases. Protein-Protein-Interaction (PPI) network was constructed using the String database, and analysis was done in Cytoscape software. The DAVID database was used for Gene Ontology enrichment and KEGG Pathways analysis. Molecular docking was performed using PyRx software and visualized in Biovia Discovery Studio. Ten compounds were identified through filtering, which include; 5-Hydroxy-7-methoxy-2-(4-methoxyphenyl)-2,3-dihydrochromen-4-one, (2s)-5-Hydroxy-7-methoxyflavanone, Apigenin, luteolin, Naringenine, Quercetin, Formononetin, cajanol, Cajanin from leaves and five from the roots namely; cajanol, Cajanin, 2'-Hydroxygenistein, Daidzein and Genistein. PPI network analysis revealed nine core target genes, including SRC, PIK3CA, EGFR, PIK3R1, IGF1R, ESR1, CTNNB1, PTK2, and AKT1. These genes were found to be involved in various biological processes such as positive regulation of phosphatidylinositol 3-kinase, negative regulation of apoptotic processes, and positive regulation of cell proliferation, and they involved endocrine resistance, PI3K-Akt signaling, and EGFR tyrosine kinase inhibitor resistance pathways. In conclusion, Cajanus cajan demonstrates anti-breast cancer potential through multi-target genes and multi-target pathway mechanisms. These findings provide a predictive foundation for further experimental validation of its therapeutic mechanisms.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.